The Oslo Medicines Initiative (OMI) has commissioned a series of technical reports to review and analyze the relevant evidence and provide policy considerations.
Two reports were authored by an WHO CC expert:
- Payer policies to support innovation and access to medicines in the WHO European Region
- Access to information in markets for medicines in the WHO European Region
Last update: 15 September 2022